-
Something wrong with this record ?
MicroRNA biogenesis, functionality and cancer relevance
B. Kusenda, M. Mraz, J. Mayer, S. Pospisilova
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
NR8448
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
17426780
DOI
10.5507/bp.2006.029
Knihovny.cz E-resources
- MeSH
- Gene Expression MeSH
- Humans MeSH
- MicroRNAs genetics physiology MeSH
- Neoplasms genetics MeSH
- Viruses genetics MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
BACKGROUND: MicroRNAs (miRNA) are small non-coding RNAs that negatively regulate gene expression in a sequence- specific manner. Post-transcriptional silencing of target genes by miRNA occurs either by specific cleavage of homologous mRNA or by specific inhibition of protein synthesis. MiRNAs are essential regulators of various processes such as proliferation, differentiation, development, cell death and interaction between virus and host cell. AIM: The aim of this paper is to summarize the main findings from research on miRNA biogenesis, functionality and cancer relevance. METHOD: A narrative literature review of all of the relevant papers known to the authors was conducted. RESULTS: Several human diseases including cancer are associated with aberrant regulation of miRNAs expression or deficiency in miRNA biogenesis. Analysis of miRNA expression signatures can serve as a valuable tool for cancer classification, diagnostics and prediction of tumor behavior. CONCLUSIONS: There has been demonstrated a possibility to use these microRNA signatures for a specific cancer classification with potential predictive and therapeutic value. The known data provide evidence that microRNAs may open new ways for cancer diagnosis, prognosis estimation and therapy.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003677
- 003
- CZ-PrNML
- 005
- 20131002142737.0
- 007
- ta
- 008
- 130128s2006 xr fd f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2006.029 $2 doi
- 035 __
- $a (PubMed)17426780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kusenda, Branislav. $7 _BN001375 $u Center of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno
- 245 10
- $a MicroRNA biogenesis, functionality and cancer relevance / $c B. Kusenda, M. Mraz, J. Mayer, S. Pospisilova
- 520 9_
- $a BACKGROUND: MicroRNAs (miRNA) are small non-coding RNAs that negatively regulate gene expression in a sequence- specific manner. Post-transcriptional silencing of target genes by miRNA occurs either by specific cleavage of homologous mRNA or by specific inhibition of protein synthesis. MiRNAs are essential regulators of various processes such as proliferation, differentiation, development, cell death and interaction between virus and host cell. AIM: The aim of this paper is to summarize the main findings from research on miRNA biogenesis, functionality and cancer relevance. METHOD: A narrative literature review of all of the relevant papers known to the authors was conducted. RESULTS: Several human diseases including cancer are associated with aberrant regulation of miRNAs expression or deficiency in miRNA biogenesis. Analysis of miRNA expression signatures can serve as a valuable tool for cancer classification, diagnostics and prediction of tumor behavior. CONCLUSIONS: There has been demonstrated a possibility to use these microRNA signatures for a specific cancer classification with potential predictive and therapeutic value. The known data provide evidence that microRNAs may open new ways for cancer diagnosis, prognosis estimation and therapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikro RNA $x genetika $x fyziologie $7 D035683
- 650 _2
- $a nádory $x genetika $7 D009369
- 650 _2
- $a viry $x genetika $7 D014780
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Mráz, Marek $7 xx0122131 $u Center of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno
- 700 1_
- $a Mayer, Jiří, $d 1960- $7 nlk20000083651 $u Center of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno
- 700 1_
- $a Pospíšilová, Šárka, $d 1969- $7 xx0101843 $u Center of Molecular Biology and Gene Therapy, Department of Internal Medicine - Hematooncology, University Hospital Brno, Brno
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 150, č. 2 (2006), s. 205-215
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20131002143254 $b ABA008
- 999 __
- $a ok $b bmc $g 966333 $s 801872
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2006 $b 150 $c 2 $d 205-215 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a NR8448 $p MZ0
- LZP __
- $b NLK111 $a Pubmed-20130128